Related Experiment Video
Updated: Jul 4, 2026
08:55
Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
Hypophosphatemic encephalopathy in a CAPD patient
Mohammad R Ardalan1, Leili Pourafkari, R Shane Tubbs
1Department of Nephrology, Tabriz University of Medical Sciences, Tabriz, Iran.
The American Journal of the Medical Sciences
|June 17, 2008
Summary
Refeeding hypophosphatemia can occur in patients on peritoneal dialysis. This case highlights transient encephalopathy and cardiac issues linked to severe hypophosphatemia in a diabetic end-stage renal disease patient.
Area of Science:
- Nephrology
- Endocrinology
- Metabolic Bone Disease
Background:
- Continuous ambulatory peritoneal dialysis (CAPD) is a treatment for end-stage renal disease (ESRD).
- Refeeding hypophosphatemia is a known complication in malnourished patients, particularly those on dialysis.
- Glucose-based solutions are commonly used in peritoneal dialysis.
Observation:
- A diabetic, malnourished ESRD patient on CAPD experienced transient encephalopathy and cardiac suppression.
- This episode was associated with severe hypophosphatemia.
- Further investigations revealed adynamic bone disease.
Findings:
- Severe hypophosphatemia can precipitate serious complications in ESRD patients undergoing peritoneal dialysis.
- The use of glucose-based solutions may contribute to electrolyte disturbances.
- Adynamic bone disease was identified as a comorbidity.
Implications:
- Clinicians should be vigilant for severe hypophosphatemia in diabetic ESRD patients on peritoneal dialysis.
- Monitoring phosphate levels is crucial during refeeding in this patient population.
- Understanding potential contributing factors is essential for preventing similar adverse events.
Related Concept Videos
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:25Peritoneal Dialysis III: Nursing Management
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:24Hemodialysis II: Procedure and Complications
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...